Practical Use of Angiotensin I/II (1-5) in Renin-Angiotensin System Research

What This Product Solves

Angiotensin I/II (1-5) (Asp-Arg-Val-Tyr-Ile peptide) addresses the need for a chemically defined and stable peptide fragment for controlled modeling of the renin-angiotensin system (RAS). This system is central to blood pressure regulation and aldosterone signaling, and the standardized fragment provides reproducibility in hypertension and renal research workflows (product_spec). By delivering a consistent substrate for in vitro and ex vivo studies, Angiotensin I/II (1-5) reduces variability associated with peptide synthesis and storage, supporting reliable investigation into mechanisms of vasoconstriction and downstream aldosterone release.

Researchers selecting this product benefit from a workflow-compatible peptide for RAS modeling, where experimental focus is on cardiovascular or renal endpoints. The compound’s defined solubility and storage parameters further reduce the risk of protocol deviations. This approach is reinforced by technical guidance in internal resources, which recommend limiting use to blood pressure, aldosterone, or renal function models (internal_article).

Protocol Parameters

• solubility (DMSO) | ≥66.5 mg/mL | solution preparation for cell-based or biochemical assays | DMSO is recommended for dissolving the peptide due to insolubility in water, enabling accurate dosing in experimental setups | product_spec
• solubility (ethanol) | ≥69.5 mg/mL | alternative solvent for in vitro or ex vivo applications | Ethanol provides a secondary option for solubilization when DMSO is incompatible with downstream assay requirements | product_spec
• storage temperature | -20°C | all research workflows | Low-temperature storage preserves peptide integrity and prevents degradation between experimental runs | product_spec
• molecular weight | 664.75 Da | calculation of molar concentrations for dosage accuracy | Accurate MW is critical for preparing stock solutions and dosing in mechanistic studies | product_spec
• application domain | cardiovascular/renal only | use in blood pressure, aldosterone, or RAS-related assays | Product should not be used outside these domains due to mechanistic specificity and limited off-target data | workflow_recommendation (internal_article)

Workflow Setup and QC Checklist

1. Solubilization: Begin by weighing an appropriate amount of Angiotensin I/II (1-5) using an analytical microbalance. Dissolve in DMSO or ethanol as per assay compatibility, ensuring the concentration does not exceed documented solubility. Vortex until fully dissolved and inspect for particulate matter. Filter-sterilize if required by downstream applications (product_spec).
2. Aliquoting and Storage: Dispense working stocks into low-binding tubes to minimize freeze-thaw cycles. Store aliquots at -20°C, avoiding repeated warming to preserve activity. Use only as much as needed for a single experiment.
3. Assay Preparation: Prior to experimental use, equilibrate aliquots to room temperature and dilute into assay buffer. Confirm compatibility of solvent (DMSO or ethanol) with cell lines or tissue preparations—final solvent concentrations should not compromise cell viability or interfere with assay readouts.
4. Quality Control: Regularly check for peptide degradation by mass spectrometry or HPLC if available, especially after prolonged storage. Document lot numbers and preparation details in lab records for traceability.

For more comprehensive workflow guidance, see the related internal article, "Angiotensin I/II (1-5): Technical Guide for Research Workflows", which details best practices specific to RAS-focused studies.

Common Failure Modes and Fixes

• Incomplete Dissolution: If peptide does not dissolve, verify solvent grade and use gentle warming (not exceeding 37°C) with consistent vortexing. Avoid water as a solvent due to documented insolubility (product_spec).
• Precipitation Upon Dilution: When diluting into aqueous buffer, add peptide solution slowly with vigorous mixing. Precipitation can be minimized by maintaining DMSO or ethanol at a compatible carrier concentration.
• Peptide Degradation: Prolonged exposure to ambient temperatures or multiple freeze-thaw cycles can degrade the peptide. Always aliquot and store at -20°C, and discard any aliquot showing cloudiness or loss of activity.
• Off-Target Effects: Using Angiotensin I/II (1-5) in non-cardiovascular or non-renal models may yield uninterpretable results due to lack of mechanistic data outside the RAS context (internal_article).

Scope and Limitations

This product is purpose-built for renin-angiotensin system research, including blood pressure regulation, aldosterone release stimulation, and hypertension studies. It should not be used in peptide signaling workflows unrelated to cardiovascular or renal function, as the peptide's specificity and solubility profile do not support broad mechanistic exploration (internal_article). Off-target or exploratory uses are not recommended without additional validation.

Furthermore, since Angiotensin I/II (1-5) is insoluble in water, experimental design must account for solvent compatibility. Researchers should review solvent effects on their model system before initiating experiments. Product is not indicated for clinical applications and should be handled in accordance with institutional safety protocols.

Conclusion

Angiotensin I/II (1-5) is a standardized Asp-Arg-Val-Tyr-Ile peptide fragment optimized for controlled modeling of the renin-angiotensin system in cardiovascular and renal research. Its defined solubility and stability parameters facilitate reproducible results in blood pressure and aldosterone signaling studies. For detailed workflow examples and expanded protocol recommendations, refer to "Angiotensin I/II (1-5): Technical Guide for Research Workflows" and "Technical Guide to Angiotensin I/II (1-5) Peptide Use in RAS Research". For ordering and full technical details, visit the APExBIO Angiotensin I/II (1-5) product page.